Cardiovascular Diseases Clinical Trial
To evaluate the impact of community educational interventions on patient delay time from onset of symptoms and signs of an acute myocardial infarction (AMI) to arrival at a hospital Emergency Department (ED). Also, to study the impact of community educational interventions on use of Emergency Medical Services (EMS) and EDs, on thrombolytic therapy, and on AMI case fatality.
BACKGROUND:
Since the advent of thrombolytic therapy, early treatment holds particular promise for
decreasing mortality from coronary heart disease. Thrombolytic therapy can reduce mortality
by 25 percent for patients treated within the first few hours of AMI symptoms, with greater
benefit the earlier the treatment. Not everyone who could benefit from receiving
thrombolytic therapy receives such therapy. One contributing factor is that many people with
symptoms do not seek emergency care in a timely manner. Studies show substantial delay times
from AMI symptoms to hospital arrival, with means ranging from 4.6 to 24 hours and medians
from 2 to 6.4 hours. EMS transport time is estimated to average 7 to 22 minutes, so a large
portion of pre-hospital delay is attributable to patient recognition and action. Several
factors have been associated with delay time. Sudden onset pain is associated with shorter
delay times, and older age, female gender, African-American race, consultation with others
about symptoms, and self-treatment programs are associated with longer delay times. There is
a need for educational programs that are effective in decreasing delay times, particularly
by focusing on people who are at increased risk of having an AMI and groups more likely to
delay seeking treatment.
Community interventions to reduce delay time between AMI symptoms and contact with the
medical system have been conducted in Britain, Canada, Sweden, Australia, Germany, King
County in Washington, and Jacksonville, Illinois. The interventions have been promising, but
the studies suffer from problems that make the reported results difficult to interpret.
Almost all the published studies assessed delay time pre-to-post intervention and had no
control or comparison group, making the magnitude and significance of impact from the
intervention difficult to determine. Most were conducted in countries other than the United
States, so applicability to the health-care system in the United States is questionable.
Although some examined the effect of a public education program on ambulance and ED
utilization, the effects of public education campaigns on use of the EMS or ED remains
unanswered.
DESIGN NARRATIVE:
The study was a multicenter, controlled community trial where the community was the unit of
assignment and of analysis. Twenty study communities were pair-matched on demographics and
one of each pair was randomly assigned to intervention and one to control. The intervention
communities received an 18-month community-based intervention to reduce delay time for
symptoms and signs of AMI, focusing on decreasing the delay time associated with patient
recognition and action. Several methods were used including: educational interventions based
on behavior change theory; patient and provider education; public education and community
organization. The primary outcome was time from symptom onset to arrival at the emergency
department. Data collection and intervention continued until competion of 18 months of
intervention.
;
Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|